• Streptozotocin in Diabetes and Neuropathy Research

  2026-10-09

  A source-grounded overview of Streptozotocin (STZ) as a diabetes research model, including its reported β-cell effects, conceptual applications, links to painful diabetic neuropathy research, evidence strength, and translational limitations.

• Flavopiridol and ER Stress in Intestinal Stem Cells

  2026-10-08

  Flavopiridol and L868275 are examined as mechanistic tools for interpreting ER-stress-related intestinal stem-cell injury, with emphasis on evidence boundaries, CDK biology, and translational relevance.

• PGF2α/PTGFR Signaling in Endometrial Breakdown

  2026-10-08

  A 2024 mouse menstrual-like model study links PGF2α/PTGFR signaling to endometrial shedding, vascular permeability, and remodeling under HIF-1α regulation. Its integrated tissue, molecular, pharmacological, and human-cell evidence clarifies a mechanistic pathway while leaving important questions about human menstruation and wider FP-receptor biology unresolved.

• Gaussia Luciferase mRNA for Lung LNP Research

  2026-10-07

  Gaussia Luciferase mRNA provides a biologically informative lens for evaluating RNA delivery, including emerging lung-targeted LNP systems. This article explains how m1Ψ-modified, capped reporter mRNA can support interpretation of delivery studies without confusing reporter expression with therapeutic benefit.

• HSBP7 Rescue of Titin Cardiomyopathy

  2026-10-07

  A preprint introduces CARDIO, a high-content morphological profiling assay for human stem cell-derived cardiomyocytes, and applies it to CRISPR perturbation of genes associated with cardiac contractile function. The study identifies HSPB7 loss as a modifier that restores contractile performance in a titin-deficient model, while emphasizing that the finding remains preclinical and requires validation in more physiologically representative systems.

• IWR-1-endo: A Cell-State Lens on Wnt Biology

  2026-10-06

  IWR-1-endo is a Wnt signaling inhibitor whose value extends beyond pathway suppression: it can help frame testable questions about cell state, β-catenin biology, and disease-associated transcriptional programs. This article connects its established colorectal cancer research applications with the cell-resolved evidence and interpretive limits of a major atrial fibrillation study.

• MMP7, EMT, and Liver Fibrosis in Biliary Atresia

  2026-10-05

  A 2026 study identifies MMP7 as a mechanistic link between epithelial–mesenchymal transition and progressive liver fibrosis in biliary atresia. Its findings connect MMP7-mediated E-cadherin cleavage with β-catenin nuclear translocation and support MMP7 blockade as a disease-relevant antifibrotic concept, while leaving important translational questions unresolved.

• mRNA-LNP Vaccines for Cryptococcosis: Evidence

  2026-10-05

  A source-grounded overview of mRNA-LNP vaccine research for cryptococcosis, explaining how T7 RNA polymerase transcription fits the broader workflow while distinguishing published murine findings from supplier claims and translational uncertainty.

• Wnt agonist 1 (BML-284): Evidence and Limits

  2026-10-03

  Wnt agonist 1, also known as BML-284, is a catalog-described small-molecule activator of β-catenin-dependent TCF transcription. Its relevance to Wnt pathway cellular differentiation research is supported by pathway and developmental-model claims, but the supplied lung cancer study does not show that BML-284 itself alters platinum resistance.

• AL-8810: A Precision Tool for FP Receptor Studies

  2026-10-02

  AL-8810 is a selective prostaglandin F2α antagonist for dissecting FP receptor signaling. This article translates recent endometrial findings into practical assay strategies spanning vascular, smooth muscle, ocular, and MMP-2 studies.

• Propidium Iodide for Granulosa Cell Assays

  2026-10-01

  Propidium iodide converts membrane damage and DNA content into practical readouts for viability, apoptosis, and cell-cycle experiments. This workflow applies the dye to ovarian granulosa-cell research, using the PCOS–AMH–SMAD4 model to sharpen assay selection, controls, and troubleshooting.

• Potato Virus X as an RNA Delivery Nanoplatform

  2026-10-01

  The reference study develops potato virus X coat protein as a programmable nucleoprotein platform for delivering custom mRNAs and circular RNAs. Its main contribution is the demonstration that filamentous, halo-shaped, mixed, and length-controlled assemblies can be built while retaining reporter transfection and protein-expression activity in eukaryotic cells.

• AL-8810: Mapping FP Receptor Causality

  2026-09-30

  AL-8810 is a selective prostaglandin F2α antagonist for resolving FP receptor signaling from downstream vascular, endometrial, and smooth-muscle phenotypes. This article translates recent PTGFR research into a causality-focused assay strategy rather than another routine workflow guide.

• ATRNL1 in Atrial Fibrillation: Single-Nucleus Evidence

  2026-09-30

  A large-scale single-nucleus RNA-seq study of human left atrial tissue identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. Functional experiments further implicate ATRNL1 in cellular stress responses and cardiac action-potential regulation, providing a mechanistic direction for future AF research.

• HyperScript™ Reverse Transcriptase for RNA-Seq

  2026-09-29

  HyperScript™ Reverse Transcriptase can strengthen follow-up cDNA synthesis for qPCR after transcriptomic discovery. This article shows how enzyme behavior becomes an assay-design variable when interpreting low-abundance and structured RNA from laying-hen hypothalamus.

8719 records 2/582 page Previous Next 12345 下5页 Last page